Xcout Intel
BrainEver competitors & alternatives
The 12 closest competitors and alternatives to BrainEver among biopharmaceuticals companies — ranked by similarity to what BrainEver actually does, not by market-cap band.
Subscribe to see BrainEver’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About BrainEver
BrainEver is a privately held biopharmaceutical company headquartered in Paris, France, focused on developing a pipeline of novel therapies.
BrainEver at a glance
BrainEver is a biopharmaceuticals company headquartered in France. Its most recent funding round, Series B, raised $35.6M in July 2025. Xcout tracks 8 named people at BrainEver, including Bernard Gilly (Chairman and CEO).
BrainEver leadership
- Bernard GillyChairman and CEO
- Claire FriedelProject Officer (CPO)
- Alain ProchiantzChief Scientific Officer (CSO)
- Anne BousseauChief Medical Officer (CMO)
- Hubert MechainChief Technological and Manufacturing Officer (CTMO)
- Alexia PerouseDirector, representative of iBionext Growth Fund participations
2 more named people on record for BrainEver, with roles, board committees and tenure — see the full roster →
BrainEver funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $35.6M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 BrainEver competitors
Ranked by semantic similarity — how close each company is to BrainEver by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biopharmaceuticals company
AgeneBio, Inc. is a development-stage CNS biopharmaceutical company located in Baltimore, Maryland, focused on discovering and developing innovative therapeutics to preserve and restore brain function.
Drug Discovery
FundaMental Pharma is a biopharmaceutical spin-off established from Heidelberg University and headquartered in Heidelberg, Germany. Its research focuses on developing novel therapeutic approaches and treatments for neurological disorders.
Drug Discovery
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
Drug Discovery
Prazer Therapeutics is a biotechnology company founded in 2019 and headquartered in Seoul, South Korea. The company focuses on developing orally available, brain-penetrating small molecule therapeutics utilizing targeted protein degradation technology for novel drug discovery.
Drug Discovery
Cyllene Therapeutics is a global leader in non-replicating HSV-1 therapeutics headquartered in Paris, France, with additional presence in New York, USA.
Similar biopharmaceuticals company
1ST Biotherapeutics is a South Korean biopharmaceutical company focused on discovering and developing treatments for neurodegenerative and other central nervous system diseases. Its work is aimed at patients with disorders such as Alzheimer’s disease and related conditions.
Drug Discovery
PulseSight Therapeutics is an ophthalmology biotechnology company headquartered in Paris, France, specializing in the development of disruptive non-viral vectorized gene therapies.
Drug Discovery
Generare is a biotechnology and artificial intelligence company headquartered in Paris, France, focused on commercial bioprospecting and decoding natural products.
Similar biopharmaceuticals company
Cerevel Therapeutics was a U.S. biopharmaceutical company focused on developing medicines for neurological and psychiatric disorders, including schizophrenia, Parkinson’s disease, and Alzheimer’s disease. Its therapies were intended to serve patients with serious central nervous system conditions and the healthcare providers treating them.
Drug Discovery
Object Pharma is a privately held biopharmaceutical company headquartered in Aliso Viejo, California, founded in 2018. The company is dedicated to developing novel treatments for mental health disorders and manufactures botulinum toxin products for accredited research use.
Similar biopharmaceuticals company
Biohaven is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments across key therapeutic areas. Headquartered with operations in New Haven, Connecticut, the company advances innovative neuroscience and specialty therapeutics.
Drug Discovery
Cognito Therapeutics Ltd. is a clinical-stage company headquartered in Cambridge, Massachusetts, that has conducted multiple clinical studies for its therapeutic products.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of BrainEver and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for BrainEverand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →